Voima Ventures is pleased to welcome Anni Harju as our new CFO & Investment Director, strengthening financial leadership and operational growth as the fund continues to back Nordic and Baltic deep tech founders from lab to global markets. In the new role, Anni will lead Voima Ventures’ finance function while also working directly with portfolio companies on scaling execution.

Anni brings an extensive operational background across growing startups and scaling tech companies. She joins Voima Ventures from her most recent role as CFO of a fast-growing Finnish scaleup in the defence sector, where she led the finance function through a period of rapid growth including doubling revenue and headcount, and expanding operations internationally. 

Before that, she was at Veri, a Helsinki-based metabolic health startup, where she served as Head of Finance and Operations before leading the company’s transition as Transition Director following its acquisition by ŌURA in late 2024.

Earlier, Anni spent close to eight years at Futurice, most recently as Head of Strategy for the Futurice Group, leading the group strategy and managing the investment portfolio.

“Raising rounds, scaling deep tech, and building exits takes more than just capital. Anni brings both us and our portfolio companies a hands-on combination of financial rigor and scaling execution across multiple deep tech sectors, including defense and health tech.”

Inka Mero, Founding Partner of Voima Ventures.

“I’ve spent my career inside scaling deep tech companies, from health tech to defence, living through the financing rounds, the international expansion, and the operational growing pains firsthand. That’s exactly the kind of operational perspective I want to bring to Voima’s portfolio companies, and I couldn’t be more excited to help build the next generation of Nordic deep tech winners.”

Anni Harju, incoming CFO & Investment Director, Voima Ventures

We’re excited to have her on board as we continue on our mission to solve major global challenges by combining science-driven innovation with entrepreneurial experience and value-adding capital.